Effect of withdrawing long-term CPAP therapy on the course of obstructive sleep apnea

Author:

Agaltsov M. V.1ORCID,Drapkina O. M.1ORCID

Affiliation:

1. National Medical Research Center for Therapy and Preventive Medicine

Abstract

Aim. To assess the effect of withdrawing long-term (12 months) CPAP therapy on the course of obstructive sleep apnea (OSA) in patients with moderate to severe disease.Material and methods. The study included 40 patients with moderate to severe OSA and paroxysmal atrial fibrillation (AF) after surgical treatment. The mean age of the subjects was 59,3+8,2 years. In addition, 55% of patients had obesity. All patients were started on CPAP therapy. After 12 months, CPAP therapy was canceled in the patients who completed the study. Additional cardiorespiratory sleep monitoring was performed 1-2 days after the withdrawal of treatment to assess the severity of sleep-related breathing disorders.Results. Cancellation of CPAP therapy in all observed cases led to an immediate relapse of OSA. Although the mean value of the apnea/hypopnea index (AHI) decreased from 24 episodes per hour [20; 34] before treatment up to 21 episodes per hour [13; 27] after 12-month CPAP therapy, there was no significant difference before and after therapy. In addition, the statistical analysis showed a transition from more severe OSA degrees to moderate ones, depending on the initial severity of the disease. Correlation analysis demonstrated significant relationships of the OSA severity, the final AHI value and the minimum oxygen level with the patient’s body weight (before and after therapy) (r=0,396, 0,411 and -0,488; r=0,358, 0,398 and -0,44, respectively, p<0,05).Conclusion. In our study, when the 12-month CPAP therapy was canceled, no complete cure for sleep-related breathing disorders was recorded in any case. OSA recurrence was recorded immediately after discontinuation of CPAP therapy (on days 1-2) and its severity depended on the initial severity of the disease. At present, the continuation of CPAP therapy remains the only way to achieve complete control of OSA as a risk factor for AF.

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3